Cargando…

5-Alkylamino-N-phenylpyrazine-2-carboxamides: Design, Preparation, and Antimycobacterial Evaluation

According to the World Health Organization, tuberculosis is still in the top ten causes of death from a single infectious agent, killing more than 1.7 million people worldwide each year. The rising resistance developed by Mycobacterium tuberculosis against currently used antituberculars is an impera...

Descripción completa

Detalles Bibliográficos
Autores principales: Ambrożkiewicz, Weronika, Kučerová-Chlupáčová, Marta, Janďourek, Ondřej, Konečná, Klára, Paterová, Pavla, Bárta, Pavel, Vinšová, Jarmila, Doležal, Martin, Zitko, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180572/
https://www.ncbi.nlm.nih.gov/pubmed/32231166
http://dx.doi.org/10.3390/molecules25071561
_version_ 1783525850051772416
author Ambrożkiewicz, Weronika
Kučerová-Chlupáčová, Marta
Janďourek, Ondřej
Konečná, Klára
Paterová, Pavla
Bárta, Pavel
Vinšová, Jarmila
Doležal, Martin
Zitko, Jan
author_facet Ambrożkiewicz, Weronika
Kučerová-Chlupáčová, Marta
Janďourek, Ondřej
Konečná, Klára
Paterová, Pavla
Bárta, Pavel
Vinšová, Jarmila
Doležal, Martin
Zitko, Jan
author_sort Ambrożkiewicz, Weronika
collection PubMed
description According to the World Health Organization, tuberculosis is still in the top ten causes of death from a single infectious agent, killing more than 1.7 million people worldwide each year. The rising resistance developed by Mycobacterium tuberculosis against currently used antituberculars is an imperative to develop new compounds with potential antimycobacterial activity. As a part of our continuous research on structural derivatives of the first-line antitubercular pyrazinamide, we have designed, prepared, and assessed the in vitro whole cell growth inhibition activity of forty-two novel 5-alkylamino-N-phenylpyrazine-2-carboxamides with various length of the alkylamino chain (propylamino to octylamino) and various simple substituents on the benzene ring. Final compounds were tested against Mycobacterium tuberculosis H37Ra and four other mycobacterial strains (M. aurum, M. smegmatis, M. kansasii, M. avium) in a modified Microplate Alamar Blue Assay. We identified several candidate molecules with micromolar MIC against M. tuberculosis H37Ra and low in vitro cytotoxicity in HepG2 cell line, for example, N-(4-hydroxyphenyl)-5-(pentylamino)pyrazine-2-carboxamide (3c, MIC = 3.91 µg/mL or 13.02 µM, SI > 38) and 5-(heptylamino)-N-(p-tolyl)pyrazine-2-carboxamide (4e, MIC = 0.78 µg/mL or 2.39 µM, SI > 20). In a complementary screening, we evaluated the in vitro activity against bacterial and fungal strains of clinical importance. We observed no antibacterial activity and sporadic antifungal activity against the Candida genus.
format Online
Article
Text
id pubmed-7180572
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-71805722020-05-01 5-Alkylamino-N-phenylpyrazine-2-carboxamides: Design, Preparation, and Antimycobacterial Evaluation Ambrożkiewicz, Weronika Kučerová-Chlupáčová, Marta Janďourek, Ondřej Konečná, Klára Paterová, Pavla Bárta, Pavel Vinšová, Jarmila Doležal, Martin Zitko, Jan Molecules Article According to the World Health Organization, tuberculosis is still in the top ten causes of death from a single infectious agent, killing more than 1.7 million people worldwide each year. The rising resistance developed by Mycobacterium tuberculosis against currently used antituberculars is an imperative to develop new compounds with potential antimycobacterial activity. As a part of our continuous research on structural derivatives of the first-line antitubercular pyrazinamide, we have designed, prepared, and assessed the in vitro whole cell growth inhibition activity of forty-two novel 5-alkylamino-N-phenylpyrazine-2-carboxamides with various length of the alkylamino chain (propylamino to octylamino) and various simple substituents on the benzene ring. Final compounds were tested against Mycobacterium tuberculosis H37Ra and four other mycobacterial strains (M. aurum, M. smegmatis, M. kansasii, M. avium) in a modified Microplate Alamar Blue Assay. We identified several candidate molecules with micromolar MIC against M. tuberculosis H37Ra and low in vitro cytotoxicity in HepG2 cell line, for example, N-(4-hydroxyphenyl)-5-(pentylamino)pyrazine-2-carboxamide (3c, MIC = 3.91 µg/mL or 13.02 µM, SI > 38) and 5-(heptylamino)-N-(p-tolyl)pyrazine-2-carboxamide (4e, MIC = 0.78 µg/mL or 2.39 µM, SI > 20). In a complementary screening, we evaluated the in vitro activity against bacterial and fungal strains of clinical importance. We observed no antibacterial activity and sporadic antifungal activity against the Candida genus. MDPI 2020-03-28 /pmc/articles/PMC7180572/ /pubmed/32231166 http://dx.doi.org/10.3390/molecules25071561 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ambrożkiewicz, Weronika
Kučerová-Chlupáčová, Marta
Janďourek, Ondřej
Konečná, Klára
Paterová, Pavla
Bárta, Pavel
Vinšová, Jarmila
Doležal, Martin
Zitko, Jan
5-Alkylamino-N-phenylpyrazine-2-carboxamides: Design, Preparation, and Antimycobacterial Evaluation
title 5-Alkylamino-N-phenylpyrazine-2-carboxamides: Design, Preparation, and Antimycobacterial Evaluation
title_full 5-Alkylamino-N-phenylpyrazine-2-carboxamides: Design, Preparation, and Antimycobacterial Evaluation
title_fullStr 5-Alkylamino-N-phenylpyrazine-2-carboxamides: Design, Preparation, and Antimycobacterial Evaluation
title_full_unstemmed 5-Alkylamino-N-phenylpyrazine-2-carboxamides: Design, Preparation, and Antimycobacterial Evaluation
title_short 5-Alkylamino-N-phenylpyrazine-2-carboxamides: Design, Preparation, and Antimycobacterial Evaluation
title_sort 5-alkylamino-n-phenylpyrazine-2-carboxamides: design, preparation, and antimycobacterial evaluation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180572/
https://www.ncbi.nlm.nih.gov/pubmed/32231166
http://dx.doi.org/10.3390/molecules25071561
work_keys_str_mv AT ambrozkiewiczweronika 5alkylaminonphenylpyrazine2carboxamidesdesignpreparationandantimycobacterialevaluation
AT kucerovachlupacovamarta 5alkylaminonphenylpyrazine2carboxamidesdesignpreparationandantimycobacterialevaluation
AT jandourekondrej 5alkylaminonphenylpyrazine2carboxamidesdesignpreparationandantimycobacterialevaluation
AT konecnaklara 5alkylaminonphenylpyrazine2carboxamidesdesignpreparationandantimycobacterialevaluation
AT paterovapavla 5alkylaminonphenylpyrazine2carboxamidesdesignpreparationandantimycobacterialevaluation
AT bartapavel 5alkylaminonphenylpyrazine2carboxamidesdesignpreparationandantimycobacterialevaluation
AT vinsovajarmila 5alkylaminonphenylpyrazine2carboxamidesdesignpreparationandantimycobacterialevaluation
AT dolezalmartin 5alkylaminonphenylpyrazine2carboxamidesdesignpreparationandantimycobacterialevaluation
AT zitkojan 5alkylaminonphenylpyrazine2carboxamidesdesignpreparationandantimycobacterialevaluation